Lowenstein represented Aetion in the acquisition of Replica Analytics, assisted by Fasken Martineau DuMoulin LLP. Aetion, the leading regulatory-grade real-world evidence (RWE) technology provider, executed its […]
Aetion’s Acquisition of Replica Analytics
Elsevier’s Acquisiton of Osmosis
Lowenstein represented Osmosis in the transaction, while Cravath represented RELX. Elsevier, a global leader in research publishing and information analytics, executed the acquisition of digital health […]
VTS’ $200 Million Acquisition of Lane Technologies
Osler, Hoskin & Harcourt and Lowenstein advised VTS on the acquisition of Lane Technologies, assisted by Fasken Martineau DuMoulin LLP. On October 19, 2021, VTS announced […]
Alloy’s $100 Million Series C Financing
Lowenstein Sandler represented Alloy in the transaction. Alloy, the leading identity decisioning platform for banks and fintech companies, executed its $100 million Series C financing. The funding […]
Zelis’ Acquisition of Sapphire Digital
Lowenstein Sandler represented Sapphire Digital in the transaction, while Kirkland & Ellis represented Zelis. Zelis, a leading payments company in healthcare, entered into a definitive agreement […]
Orchard’s $100 Million Series D Funding
Lowenstein represented Orchard in the transaction. Orchard, the company that is radically simplifying home buying and selling, executed its $100 million Series D funding at over a […]
Celldex Therapeutics’ $287.5 Million Common Stock Offering
Lowenstein Sandler represented Celldex Therapeutics in the offering. Celldex Therapeutics, Inc. (Celldex) (Nasdaq: CLDX) executed its $287.5 million public offering of common stock. Jefferies, SVB Leerink, […]
VTS’s Acquisition of Rise Buildings
Lowenstein Sandler represented VTS in the transaction. VTS executed the acquisition of Rise Buildings, a Chicago-based startup. Rise Buildings is the property operations and tenant experience technology company […]